TAUNS Laboratories,Inc. (TYO:197A)

Revenue by Segment

Financials in millions JPY. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
In-vitro Diagnostic Pharmaceutical	18.43B
In-vitro Diagnostic Pharmaceutical Growth	17.62%

Revenue by Geography

Financials in millions JPY. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Japan	17.82B
Japan Growth	15.79%
United Kingdom	90.71M
United Kingdom Growth	75.72%
Other	524.59M
Other Growth	126.80%